[A case of multiple sclerosis with a tumefactive lesion during long-term treatment with fingolimod, leading to decompressive craniotomy].
Rinsho Shinkeigaku
; 63(1): 37-44, 2023 Jan 28.
Article
in Ja
| MEDLINE
| ID: mdl-36567105
ABSTRACT
We report a 57-year-old man with multiple sclerosis since his 30s who was treated with fingolimod for 9 years. He developed left hemiparesis and consciousness disturbance. Brain MRI revealed a mass lesion in the right frontal lobe with gadolinium enhancement. Cerebrospinal fluid examination showed no pleocytosis. The lesion continued to expand after admission, and on the 9th day after admission, decompressive craniectomy and brain biopsy were performed. Brain pathology revealed demyelination in the lesion, leading to the diagnosis of a tumefactive demyelinating lesion. Corticosteroid therapy ameliorated the brain lesion, and we inducted natalizumab. Tumefactive demyelinating lesions requiring decompressive craniotomy are rare, and we report this case for the further accumulation of similar cases.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Decompressive Craniectomy
/
Multiple Sclerosis
Limits:
Humans
/
Male
/
Middle aged
Language:
Ja
Journal:
Rinsho Shinkeigaku
Year:
2023
Document type:
Article